Cambrex Unveils $120 Million Investment to Expand API Manufacturing and Strengthen U.S. Drug Supply Resilience

URLhttps://www.eqs-news.com/news/corporate/cambrex-un
SourceEQS News
Date Published10/22/2025

Additional Reshoring Information:

Company/Division name Cambrex
Parent companyPermira
Type of work Manufacturing
Reshoring category:Reshoring
Year reshoring announced:2025
Domestically, the work will be done:In-house
Capital investment ($):120
City reshored to:Charles City
State(s) reshored to:IA
If relevant, work nearshored to:-
Industry(ies):Chemicals
Product(s) reshoredactive pharmaceutical ingredients
What domestic positive factors made reshoring more attractive?Eco-system synergies
Find Reshoring Articles